Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation (VORTAL)

April 9, 2024 updated by: Azam Babadjanov, Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov

Verification of Prognostic Risk Factors of Thrombohemorrhagic Complications in Early Follow-up Period in Recipients After Living Related Liver Transplantation

The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Uzbekistan
      • Tashkent, Uzbekistan, 100115
        • Recruiting
        • Republican specialized scientific and practical medical center of surgery named after academician V.Vakhidov
        • Contact:
          • Azam Babadjanov, Professor
          • Phone Number: +998901751703
          • Email: azam746@mail.ru

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients with end stage liver cirrhosis who underwent living related liver transplantation.

Description

Inclusion Criteria:

  • Age over 18 years and up to 70 years;
  • Signed informed consent for inclusion to the study;
  • End stage liver cirrhosis.

Exclusion Criteria:

  • Pregnancy;
  • Extrahepatic factors influencing systemic hemostasis;
  • Concomitant hematological diseases affecting the hemostatic system;
  • Severe concomitant disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
liver transplant group
Procedure: Liver transplantation
Related transplantation of the right lobe of the liver

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thrombosis of vascular anastomosis
Time Frame: 1 month
Thrombosis of arterial or venous anastomosis after intervention
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hemorrhagic complications
Time Frame: 1 month
Any hemorrhagic complications after intervention
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 22, 2022

Primary Completion (Estimated)

August 14, 2024

Study Completion (Estimated)

September 14, 2024

Study Registration Dates

First Submitted

December 5, 2023

First Submitted That Met QC Criteria

December 5, 2023

First Posted (Actual)

December 13, 2023

Study Record Updates

Last Update Posted (Actual)

April 10, 2024

Last Update Submitted That Met QC Criteria

April 9, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 05122023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Liver Cirrhosis

Clinical Trials on Liver transplantation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe